Literature DB >> 34074137

Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association.

Bethany Barone Gibbs, Marie-France Hivert, Gerald J Jerome, William E Kraus, Sara K Rosenkranz, Erica N Schorr, Nicole L Spartano, Felipe Lobelo.   

Abstract

Current guidelines published by the American Heart Association and the American College of Cardiology broadly recommend lifestyle approaches to prevent and treat elevated blood pressure and cholesterol. For patients with mildly or moderately elevated blood pressure and blood cholesterol, lifestyle-only approaches are the first line of therapy. The purpose of this scientific statement is to: (1) highlight the mild-moderate-risk patient groups indicated for lifestyle-only treatment for elevated blood pressure or cholesterol; (2) describe recommendations, average effects, and additional considerations when prescribing lifestyle treatment with physical activity; and (3) provide guidance and resources for clinicians to assess, prescribe, counsel, and refer to support increased physical activity in their patients. An estimated 21% and 28% to 37% of US adults, respectively, have mild-moderate-risk blood pressure and cholesterol and should receive lifestyle-only as first-line treatment. Of the recommended lifestyle changes, increasing physical activity has extensive benefits, including improving both blood pressure and blood cholesterol, that are comparable, superior, or complementary to other healthy lifestyle changes. Physical activity assessment and prescription are an excellent lifestyle behavior treatment option for all patients, including for the large population of mild-moderate-risk patients with elevated blood pressure and blood cholesterol.

Entities:  

Keywords:  AHA Scientific Statements; blood pressure; exercise; hypertension; lifestyle; risk reduction behavior

Mesh:

Year:  2021        PMID: 34074137     DOI: 10.1161/HYP.0000000000000196

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function.

Authors:  Tatsuya Maruhashi; Yukihito Higashi
Journal:  Hypertens Res       Date:  2022-05-20       Impact factor: 5.528

2.  NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.

Authors:  Nanette F Santoro; Helen L Coons; Samar R El Khoudary; C Neill Epperson; Julianne Holt-Lunstad; Hadine Joffe; Sarah H Lindsey; Kara L Marlatt; Patti Montella; Gloria Richard-Davis; Bonny Rockette-Wagner; Marcel E Salive; Cynthia Stuenkel; Rebecca C Thurston; Nancy Woods; Holly Wyatt
Journal:  Menopause       Date:  2022-05-01       Impact factor: 3.310

3.  Associations of Adherence to the DASH Diet and the Mediterranean Diet With All-Cause Mortality in Subjects With Various Glucose Regulation States.

Authors:  Jun-Sing Wang; Wei-Ju Liu; Chia-Lin Lee
Journal:  Front Nutr       Date:  2022-01-27

4.  Hypertension Update: A Reflection of the Past Decade.

Authors:  Anna F Dominiczak; Trudie J Meyer
Journal:  Hypertension       Date:  2021-11-10       Impact factor: 10.190

5.  Association of Adherence to the Mediterranean Diet with All-Cause Mortality in Subjects with Heart Failure.

Authors:  Chih-Yun Chang; Chia-Lin Lee; Wei-Ju Liu; Jun-Sing Wang
Journal:  Nutrients       Date:  2022-02-17       Impact factor: 5.717

6.  Breaking barriers to remain healthy and fit during a residency in anaesthesiology.

Authors:  Swati Chhabra; Naveen Malhotra; Sukhminder Jit Singh Bajwa; Sanjay Choubey; Shibu Sasidharan; Neeru Sahni
Journal:  Indian J Anaesth       Date:  2022-02-03

7.  Effects of Aquatic Exercise in Post-exercise Hypotension: A Systematic Review and Meta-Analysis.

Authors:  Cristina Oliveira Trindade; Emerson Cruz Oliveira; Daniel Barbosa Coelho; Juliano Casonatto; Lenice Kappes Becker
Journal:  Front Physiol       Date:  2022-01-31       Impact factor: 4.566

8.  Machine Learning Methods for Hypercholesterolemia Long-Term Risk Prediction.

Authors:  Elias Dritsas; Maria Trigka
Journal:  Sensors (Basel)       Date:  2022-07-18       Impact factor: 3.847

9.  Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021.

Authors:  Boonsub Sakboonyarat; Jaturon Poovieng; Kanlaya Jongcherdchootrakul; Phutsapong Srisawat; Panadda Hatthachote; Mathirut Mungthin; Ram Rangsin
Journal:  BMC Public Health       Date:  2022-08-17       Impact factor: 4.135

10.  Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk.

Authors:  Michael Böhm; Helmut Schumacher; Christian Werner; Koon K Teo; Eva M Lonn; Felix Mahfoud; Thimoteus Speer; Giuseppe Mancia; Josep Redon; Roland E Schmieder; Karen Sliwa; Nikolaus Marx; Michael A Weber; Ulrich Laufs; Bryan Williams; Salim Yusuf; Johannes F E Mann
Journal:  Cardiovasc Diabetol       Date:  2022-01-20       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.